Additionally, similarly to gastric cancer, HADH downregulation was significantly associated with poor OS, DFS, and poor prognosis in kidney renal clear cell carcinoma (Zhang et al., 2019; Jiang et al., 2021; Sun et al., 2022). The gene discussed is HADH; the disease is gastric cancer.